PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-138

  1. 3,322 Posts.
    lightbulb Created with Sketch. 321
    Akki you are just funny. So in your way of thinking if somebody get to same conclusion that do not match with your way of thinking they must be the same person…..you just laughable.
    Fact is that yes you may not have anything against management but for sure I haven’t seen you posting anything positive ref PER and/or drug’s pipeline. Is that possible there nothing you like in the PER story? Then why are you here?
    And no I am not insulsa and don’t even know him/her so put your “adventurous” extra sense on rest.
    P.S. if by a very unexpected motive you, in your high intellectual mind, come across something positive about PER would you be kind enough to share with all of us here?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $9.786M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $94.66K 10.09M

Buyers (Bids)

No. Vol. Price($)
4 661860 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1588275 6
View Market Depth
Last trade - 15.52pm 27/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.